Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."
N/A
To evaluate the incidence of grade 3 or 4 transaminase elevations or grade ...
Status
Completed
Location
Fundación Pública Andaluza Progreso y Salud
Start Date
2014-05
Trial ID
NCT02196064
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants
PHASE3
The primary objective of this study is to evaluate the efficacy of switchin...
Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)
PHASE1
Single-arm, single-center, Phase I/II clinical trial, in four groups. Indiv...
Status
Completed
Location
The Aurum Institute: Tembisa Clinical Research Centre